{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:14:27Z","timestamp":1790781267945,"version":"4.1.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T00:00:00Z","timestamp":1230249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000249","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T21:15:58Z","timestamp":1230326158000},"page":"e1000249","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Surviving Mousepox Infection Requires the Complement System"],"prefix":"10.1371","volume":"4","author":[{"given":"Elizabeth A.","family":"Moulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark L","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism.","volume":"283","author":"DA Henderson","year":"1999","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: An emerging zoonotic disease.","volume":"2","author":"S Parker","year":"2007","journal-title":"Future Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism.","volume":"3","author":"G McFadden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"ref4","first-page":"67","article-title":"Mousepox.","author":"RM Buller","year":"2007"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0402949101","article-title":"Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.","volume":"101","author":"G Chaudhri","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/JVI.70.12.8301-8309.1996","article-title":"Different roles for CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T lymphocytes and macrophage subsets in the control of a generalized virus infection.","volume":"70","author":"G Karupiah","year":"1996","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8<sup>+<\/sup> T Cells are complementary and essential for natural resistance to a highly lethal cytopathic virus.","volume":"175","author":"M Fang","year":"2005","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection.","volume":"80","author":"G Chaudhri","year":"2006","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1371\/journal.ppat.0040030","article-title":"A role for NKG2D in NK cell-mediated resistance to poxvirus disease.","volume":"4","author":"M Fang","year":"2008","journal-title":"PLoS Pathogens"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/JVI.02061-06","article-title":"Induction of natural killer cell responses by ectromelia virus controls infection.","volume":"81","author":"AK Parker","year":"2007","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2427(98)00086-5","article-title":"Type 1 and type 2 cytokines in antiviral defense.","volume":"63","author":"G Karupiah","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/JVI.67.7.4214-4226.1993","article-title":"Importance of interferons in recovery from mousepox.","volume":"67","author":"G Karupiah","year":"1993","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1073\/pnas.0505180102","article-title":"Interferon function is not required for recovery from a secondary poxvirus infection.","volume":"102","author":"V Panchanathan","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.73.2.1665-1667.1999","article-title":"Perforin is essential for control of ectromelia virus but not related poxviruses in mice.","volume":"73","author":"A Mullbacher","year":"1999","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/08828240151061428","article-title":"Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicity.","volume":"14","author":"R Wallich","year":"2001","journal-title":"Viral Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.96.24.13950","article-title":"Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.","volume":"96","author":"A Mullbacher","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2006.03.018","article-title":"Emerging patterns in complement-mediated pathogen recognition.","volume":"125","author":"R Roozendaal","year":"2006","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","article-title":"Complement: Central to innate immunity and bridging to adaptive responses.","volume":"97","author":"BP Morgan","year":"2005","journal-title":"Immunol Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molimm.2004.06.011","article-title":"Complement: A unique innate immune sensor for danger signals.","volume":"41","author":"P Gasque","year":"2004","journal-title":"Molecular Immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0168-8278(02)00205-2","article-title":"C4A deficiency and nonresponse to hepatitis B vaccination.","volume":"37","author":"T Hohler","year":"2002","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(02)00369-2","article-title":"Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection.","volume":"17","author":"SB Kapadia","year":"2002","journal-title":"Immunity"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.","volume":"8","author":"M Kopf","year":"2002","journal-title":"Nat Med"},{"key":"ref23","article-title":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways.","author":"E Mehlhop","year":"2006","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1086\/323462","article-title":"Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections.","volume":"33","author":"M Seppanen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2003.11.029","article-title":"The relevance of complement to virus biology.","volume":"319","author":"CE Blue","year":"2004","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.18709-0","article-title":"Virus complement evasion strategies.","volume":"84","author":"HW Favoreel","year":"2003","journal-title":"J Gen Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens.","volume":"6","author":"JD Lambris","year":"2008","journal-title":"Nat Rev Micro"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.imbio.2006.01.003","article-title":"Lectin complement system and pattern recognition.","volume":"211","author":"Y Endo","year":"2006","journal-title":"Immunobiology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease.","volume":"176","author":"JM Thurman","year":"2006","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0161-5890(01)00041-4","article-title":"Anaphylatoxins and infectious and non-infectious inflammatory diseases.","volume":"38","author":"J Kohl","year":"2001","journal-title":"Mol Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/vim.2007.0061","article-title":"Role of complement in immune regulation and its exploitation by virus.","volume":"20","author":"KL Cummings","year":"2007","journal-title":"Viral Immunology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity.","volume":"5","author":"MC Carroll","year":"2004","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.89.2.628","article-title":"Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.","volume":"89","author":"SN Isaacs","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tim.2003.08.004","article-title":"\u2018Complementing\u2019 viral infection: Mechanisms for evading innate immunity.","volume":"11","author":"SH Lee","year":"2003","journal-title":"Trends Microbiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1128\/JVI.77.11.6093-6100.2003","article-title":"Poxvirus immunomodulatory strategies: Current perspectives.","volume":"77","author":"JB Johnston","year":"2003","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-1702(02)00119-3","article-title":"Poxvirus immune modulators: Functional insights from animal models.","volume":"88","author":"PC Turner","year":"2002","journal-title":"Virus Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1462-5822.2004.00423.x","article-title":"Technical knockout: Understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes.","volume":"6","author":"JB Johnston","year":"2004","journal-title":"Cell Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","article-title":"Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens.","volume":"124","author":"BB Finlay","year":"2006","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors.","volume":"3","author":"A Alcami","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.174.4.2143","article-title":"Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins.","volume":"174","author":"G Sfyroera","year":"2005","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1073\/pnas.112220499","article-title":"Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement.","volume":"99","author":"AM Rosengard","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.2237434","article-title":"Inhibition of the complement cascade by the major secretory protein of vaccinia virus.","volume":"250","author":"GJ Kotwal","year":"1990","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.gene.2005.05.008","article-title":"Evolutionary history of orthopoxvirus proteins similar to human complement regulators.","volume":"355","author":"E Ciulla","year":"2005","journal-title":"Gene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.181.6.4199","article-title":"Smallpox inhibitor of complement enzymes (SPICE): Regulation of complement activation on cells and mechanism of its cellular attachment.","volume":"181","author":"MK Liszewski","year":"2008","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","article-title":"Structure and regulatory profile of the monkeypox inhibitor of complement: Comparison to homologs in vaccinia and variola and evidence for dimer formation.","volume":"176","author":"MK Liszewski","year":"2006","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin.","volume":"340","author":"N Chen","year":"2005","journal-title":"Virology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/viro.1996.8396","article-title":"The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein.","volume":"229","author":"CG Miller","year":"1997","journal-title":"Virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/cimm.1995.1086","article-title":"Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: Investigation of the role of host complement in poxvirus pathogenesis.","volume":"162","author":"CG Miller","year":"1995","journal-title":"Cell Immunol"},{"key":"ref49","first-page":"1407","article-title":"Differential pathogenesis of lethal mousepox in congenic DBA\/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen.","volume":"150","author":"DG Brownstein","year":"1997","journal-title":"Am J Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-3089.2005.00237.x","article-title":"\u201cHomologous restriction\u201d in complement lysis: Roles of membrane complement regulators.","volume":"12","author":"B Paul Morgan","year":"2005","journal-title":"Xenotransplantation"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","article-title":"Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.","volume":"83","author":"DC Tscharke","year":"2002","journal-title":"J Gen Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/icb.1960.30","article-title":"Studies on the innate resistance of mice to infection with mousepox. II. Route of inoculation and resistance; and some observations on the inheritance of resistance.","volume":"38","author":"K Schell","year":"1960","journal-title":"Aust J Exp Biol Med Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.190.8.1165","article-title":"Protective T cell-independent antiviral antibody responses are dependent on complement.","volume":"190","author":"AF Ochsenbein","year":"1999","journal-title":"J Exp Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1073\/pnas.96.22.12708","article-title":"Humoral response to herpes simplex virus is complement-dependent.","volume":"96","author":"XJ Da Costa","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.4049\/jimmunol.167.5.2446","article-title":"Cutting edge: Myeloid complement C3 enhances the humoral response to peripheral viral infection.","volume":"167","author":"A Verschoor","year":"2001","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.170.2.788","article-title":"Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection.","volume":"170","author":"M Suresh","year":"2003","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1128\/JVI.79.12.7466-7477.2005","article-title":"Complement activation is required for induction of a protective antibody response against West Nile virus infection.","volume":"79","author":"E Mehlhop","year":"2005","journal-title":"J Virol"},{"key":"ref58","first-page":"16","article-title":"Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.","volume":"37","author":"RO Jacoby","year":"1987","journal-title":"Lab Anim Sci"},{"key":"ref59","first-page":"535","article-title":"Mousepox.","author":"F Fenner","year":"1997"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.","volume":"81","author":"JP Jayasekera","year":"2007","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","article-title":"Control of early viral and bacterial distribution and disease by natural antibodies.","volume":"286","author":"AF Ochsenbein","year":"1999","journal-title":"Science"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1073\/pnas.0701822104","article-title":"Memory CD8<sup>+<\/sup> T cells are gatekeepers of the lymph node draining the site of viral infection.","volume":"104","author":"RH Xu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus.","volume":"83","author":"GL Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.","volume":"95","author":"A Vanderplasschen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens.","volume":"124","author":"KY Helmy","year":"2006","journal-title":"Cell"},{"key":"ref66","first-page":"533","article-title":"The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus.","volume":"40","author":"CA Mims","year":"1959","journal-title":"Br J Exp Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.","volume":"78","author":"JW Hooper","year":"2004","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.","volume":"105","author":"PL Earl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.","volume":"26","author":"KA Marriott","year":"2008","journal-title":"Vaccine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.","volume":"11","author":"Y Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.","volume":"101","author":"PB Jahrling","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref73","first-page":"Unit16.17","article-title":"Generation of recombinant vaccinia viruses.","volume":"Chapter 16","author":"PL Earl","year":"2001","journal-title":"Curr Protoc Mol Biol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene.","volume":"187","author":"W Chen","year":"1992","journal-title":"Virology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0162-3109(99)00021-1","article-title":"Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA.","volume":"42","author":"A Circolo","year":"1999","journal-title":"Immunopharmacology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.94.16.8720","article-title":"Abrogation of the alternative complement pathway by targeted deletion of murine factor B.","volume":"94","author":"M Matsumoto","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.4049\/jimmunol.181.4.2732","article-title":"Membrane protein Crry maintains homeostasis of the complement system.","volume":"181","author":"X Wu","year":"2008","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.157.2.549","article-title":"Regulation of the B cell response to T-dependent antigens by classical pathway complement.","volume":"157","author":"M Fischer","year":"1996","journal-title":"J Immunol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin [mu] chain gene.","volume":"350","author":"D Kitamura","year":"1991","journal-title":"Nature"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.","volume":"19","author":"M Botto","year":"1998","journal-title":"Nat Genet"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"14577","DOI":"10.1073\/pnas.261428398","article-title":"Complement activation in factor D-deficient mice.","volume":"98","author":"Y Xu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.18.5.1220-1225.1983","article-title":"Evaluation of an enzyme-linked immunosorbent assay for the detection of ectromelia (mousepox) antibody.","volume":"18","author":"RM Buller","year":"1983","journal-title":"J Clin Microbiol"},{"key":"ref83","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.","author":"S Parker","year":"2008","journal-title":"Antiviral Therapy"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:43:40Z","timestamp":1684820620000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000249"}},"subtitle":[],"editor":[{"given":"Klaus","family":"Fr\u00fch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,12,26]]},"references-count":83,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2008,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000249","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,26]]}}}